HOME >> BIOLOGY >> NEWS
NYU researchers discover mechanism linking color vision and cancer genes

Biologists at New York University have discovered a system by which a random choice between two distinct cellular fates in the fruit fly eye becomes firmly established. Surprisingly, the genes involved are known 'tumor suppressor genes', i.e. genes that are inactivated in some forms of cancer due to uncontrolled cell proliferation. Because the fly eye is highly amenable to genetic analysis, these findings, published in the latest issue of Cell, could help decipher the mechanisms by which genes that control cell proliferation and cell growth are themselves regulated.

In this study, researchers from Dr. Claude Desplan's laboratory in the Center for Developmental Genetics at NYU Biology used the fly eye to understand the mechanism that affects the choice between photoreceptors that allows color discrimination: A given color photoreceptor can randomly decide to express a blue, or a green photopigment, but expressing both would lead to sensory confusion. Therefore, a switch mechanism ensures that photoreceptors make an unambiguous decision. Interestingly, the genes involved in this switch appear to be part of a tumor suppressor pathway.

Researchers have recently uncovered processes by which groups of genes work together to affect the number and size of cells. These genes are often affected in cancers where cells proliferate in an uncontrolled manner. Less clear, however, are the upstream mechanisms that control this genetic activity: Understanding the regulation of these pathways is essential as it would enhance our ability to control processes by which cancer cells replicate or die. Although the photoreceptors have long completed their last cell division, they appear to re-utilize the genetic pathways known to control cell proliferation and cell size to achieve a stable state.

"These genes form a bistable loop that insures a robust commitment of color photoreceptors that does allow ambiguity," said Desplan, the study's corresponding author.
'"/>

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
8-Sep-2005


Page: 1 2

Related biology news :

1. Innovative tagging technique may help researchers better protect fish stocks
2. Penn researchers discover how key protein stops inflammation
3. ASU researchers partner with UOP to make biofuel for military jets a reality
4. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
5. Penn researchers discover pathway that eliminates genetic defects in red blood cells
6. U-M researchers find family of on switches that cause prostate cancer
7. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
8. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
9. MGH researchers confirm that bone marrow restores fertility in female mice
10. Smithsonians National Zoo researchers use electronic eggs to help save threatened species
11. U-M researchers identify gene involved in breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... July 31, 2019 , ... Molecular Devices, LLC, a leader ... generation of its FLIPR® Penta High-Throughput Cellular Screening System. , The new FLIPR ... of G-protein-coupled receptors (GPCRs) and ion channels, offering a new high-speed camera option ...
(Date:7/26/2019)... ... July 25, 2019 , ... Lemnis Technologies, the technology ... to include a new generation eye tracker with hassle-free calibration. The headsets will ... (July 30 - August 1). SIGGRAPH attendees will be able to try Verifocal™ ...
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... of NanoSTRIP, a 100% bioactive glass synthetic biologic strip indicated for spine and ... (HA) similar to human bone. Bioactive glass has been clinically-proven in orthopedics for ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... Personalized ... Investigational New Drug (IND) application to the FDA for use of a person’s own ... as a treatment of osteoarthritis in the knee. This IND is the first ...
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... ... 11, 2019 , ... Veterinary Regenerative Medicine company, VetStem ... announced that their GMP facility for cell production is now approved by the ... is an important milestone for VetStem as it expands into contract cell manufacturing ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
Breaking Biology Technology:
Cached News: